Human T-Cell Leukemia Virus (HTLV-I) Antibodies in Africa
W. Carl Saxinger(National Cancer Institute), Robert C. Gallo(University of South Florida), Mei Hoh(National Cancer Institute), Robert J. Jacobson(Georgetown University), A. G. Dean(Centre international de recherche sur le cancer), N Mourali(Institut Salah-Azaïz), Jasmine Moghissi(National Cancer Institute), L. Wilson(University of Cape Town), Jeffrey W. Clark(Massachusetts General Hospital), Michael J. Strong(Louisiana Cancer Research Center), Robert J. Biggar(National Institutes of Health), Paul H. Levine(National Cancer Institute), William A. Blattner(Unknown), Peter Jacobs(Stellenbosch University), Asif Ansari(Naval Medical Research Unit EURAFCENT), F K Nkrumah(University of Ghana), Robert Crookes
Cited by 227
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k